Clinical Trials Directory

Trials / Completed

CompletedNCT02648451

Acceptability and Tolerance Study of New Oral Nutritional Supplement

Tolerance and Acceptability of AYMES ROME

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Aymes International Limited · Industry
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

* To evaluate tolerance and acceptability of AYMES ROME in patients requiring supplementary oral nutritional support compared with currently available alternatives. * To obtain data to support a submission to Advisory Committee on Borderline Substances (ACBS) for AYMES ROME (to allow for prescription in the community at National Health Service (NHS) expense).

Detailed description

To evaluate tolerance and acceptability of AYMES ROME in patients requiring supplementary oral nutritional support compared with currently available alternatives, measuring outcomes of GI effects, Compliance, product preference,convenience etc. To obtain data to support an ACBS submissions for AYMES ROME (to allow for prescription in the community at NHS expense).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAYMES ROMEAYMES Rome is a powder, designed to be mixed with 250 ml water to make up a juice style ONS. When made up AYMES Rome provides 300 kcal (1 kcal / ml) and 10.7 g protein. It is not designed to be used as a sole source of nutrition. It is a Food for Special Medical Purposes (FSMP) and must therefore be used under medical supervision.

Timeline

Start date
2015-01-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2016-01-07
Last updated
2016-01-07

Source: ClinicalTrials.gov record NCT02648451. Inclusion in this directory is not an endorsement.